Real-World Multicenter Evaluation of MEMOTIN® for Tinnitus in Private Clinic Settings: The M.E.S.T Study.

There is currently no universally effective treatment for subjective tinnitus, and management strategies focus on the relief of symptoms rather than a definite cure. In line with this, our prospective, non-interventional, non-placebo-controlled, multicenter clinical study, conducted in private clinics, evaluates the efficacy of taking a daily supplement based on active compounds in alleviating tinnitus-related disability. The study was conducted in adults with tinnitus who were instructed to take one capsule daily, 30 minutes before bedtime, for a duration of three months between March 30 and December 20, 2024. This study aims to provide valuable clinical insights into the potential therapeutic benefits of a dietary supplement in alleviating the symptoms of tinnitus and improving patients' quality of life. Employing validated assessment tools, such as the Tinnitus Handicap Inventory (THI), this study seeks to provide objective evidence regarding the potential benefits of MEMOTIN® as a supportive intervention for individuals suffering from tinnitus.